The new NCCN Guidelines for Patients & Quick Guide Series has published a guide for patients experiencing nausea and vomiting from their chemotherapy treatment, as mesothelioma and other cancer patients often do.
Experts estimate that 90 percent of patients who receive highly emetogenic chemotherapy (chemo regimens linked to a high incidence of nausea and vomiting) experience that side effect, making it one of the most feared effects of cancer treatment, according to the National Comprehensive Cancer Network (NCCN).
Nausea and vomiting, aside from affecting patients’ quality of life, can lead to poor compliance to chemotherapy or radiation therapy and bring serious complications to a person’s overall health, including metabolic imbalances and dehydration.
Although there are treatments for nausea and vomiting, they can only reduce the incidence of the side effects by about 30 percent.
“At NCCN, our mission is to improve the lives of patients with cancer, and we are excited to be able to provide the information that will help patients better understand this common side effect of cancer treatment,” Marcie R. Reeder, MPH, executive director at the NCCN Foundation, said in a press release.
“The NCCN Guidelines for Patients for Nausea and Vomiting are the first of a highly anticipated library of supportive care resources that provide patients with the same information their doctors use,” she said.
All NCCN Guidelines are one-page summaries of key points written in plain language and include patient-friendly elements, such as questions to ask your doctor, a glossary of terms, and medical illustrations of anatomy, tests, and treatments.
The NCCN Guidelines are easy-to-understand translations of the NCCN Clinical Practice Guidelines in Oncology. They are based on the same clinical practice guidelines used by medical professionals worldwide to determine the best way to treat a patient with cancer.
Each resource features unbiased expert guidance to assist people in discussions with their physicians about their best treatment options.
The Guidelines were also launched on the new NCCN Patients Guides for Cancer mobile app earlier this month (November). The new app is available free of charge for Android and iOS devices and features the complete library of NCCN Guidelines.
“With the launch of the new mobile app, patients and caregivers have easy-to-understand cancer treatment information at the tips of their fingers. We are excited to deliver this world-class information to all audiences, whether in print, online, or via mobile device,” Reeder added.